
Medical
3645.TMedical Net, Inc. Price (3645.T)
$313
-2.1875%Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
9,045,270
(0.9423)%2023 - Income Statement Summary
Revenue | 5.25B USD |
Cost of Revenue | 3.41B USD |
Gross Profit | 1.84B USD |
Operating Expenses | 1.54B USD |
Operating Income | 298.28M USD |
Other Expenses | 0.00 USD |
Net Income | 5.96M USD |


Income Statement
Medical Net, Inc.Currency: JPY
YEAR | 2019 | 2020 | 2021 | 2022 | 2023 | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||||||||||||
Revenue |
2,917,867,000.00
+0% |
2,904,602,000.00
0% |
3,745,765,000.00
+29% |
4,500,846,000.00
+20% |
5,252,061,000.00
+17% |
||||||||||||||
Cost of Revenue | |||||||||||||||||||
Cost of Revenue | 1,945,469,000.00 | 1,726,443,000.00 | 2,285,724,000.00 | 2,719,711,000.00 | 3,411,058,000.00 | ||||||||||||||
Gross Profit | |||||||||||||||||||
Gross Profit |
972,398,000.00
+0% |
1,178,159,000.00
+21% |
1,460,041,000.00
+24% |
1,781,135,000.00
+22% |
1,841,003,000.00
+3% |
||||||||||||||
Gross Profit Ratio | (0.33%) | (0.41%) | (0.39%) | (0.40%) | (0.35%) | ||||||||||||||
Operating Expenses | |||||||||||||||||||
Research and Development | 10,000,000.00 | 11,000,000.00 | 8,000,000.00 | 0.00 | 7,000,000.00 | ||||||||||||||
General and Administrative | 112,000,000.00 | 118,000,000.00 | 149,000,000.00 | 157,000,000.00 | 173,000,000.00 | ||||||||||||||
Selling, General & Admin... | 866,000,000.00 | 846,000,000.00 | 1,010,000,000.00 | 1,401,000,000.00 | 1,535,952,000.00 | ||||||||||||||
Selling & Marketing Exp... | 131,000,000.00 | 72,000,000.00 | 108,000,000.00 | 119,000,000.00 | 119,000,000.00 | ||||||||||||||
Depreciation and Amortiz... | 20,666,000.00 | 24,859,000.00 | 35,063,000.00 | 62,072,000.00 | 53,815,000.00 | ||||||||||||||
Other Expenses | -9,105,000.00 | 4,928,000.00 | -1,869,000.00 | 6,521,000.00 | 0.00 | ||||||||||||||
Total Operating Expenses | 866,018,000.00 | 846,889,000.00 | 1,014,919,000.00 | 1,401,483,000.00 | 1,542,722,000.00 | ||||||||||||||
Cost and Exponses | 2,811,487,000.00 | 2,573,332,000.00 | 3,300,643,000.00 | 4,121,194,000.00 | 4,953,780,000.00 | ||||||||||||||
Operating Income | |||||||||||||||||||
Operating Income |
106,378,000.00
+0% |
331,269,000.00
+211% |
445,120,000.00
+34% |
379,650,000.00
-15% |
298,281,000.00
-21% |
||||||||||||||
Operating Income Ratio | (0.04%) | (0.11%) | (0.12%) | (0.08%) | (0.06%) | ||||||||||||||
Other Income and Exp... | |||||||||||||||||||
Interest Income | 640,000.00 | 673,000.00 | 690,000.00 | 841,000.00 | 1,143,000.00 | ||||||||||||||
Interest Expenses | 2,158,000.00 | 1,896,000.00 | 1,974,000.00 | 3,026,000.00 | 6,422,000.00 | ||||||||||||||
Total Other Income/Exp... | -2,028,000.00 | -77,180,000.00 | 88,655,999.00 | -128,907,000.00 | -145,231,000.00 | ||||||||||||||
EBITDA | |||||||||||||||||||
EBITDA | 126,797,000.00 | 280,844,000.00 | 570,812,000.00 | 315,839,000.00 | 213,291,000.00 | ||||||||||||||
EBITDA ratio | (0.04%) | (0.13%) | (0.13%) | (0.11%) | (0.04%) | ||||||||||||||
Income Before Tax | |||||||||||||||||||
Income Before Tax | 103,972,000.00 | 254,089,000.00 | 533,776,000.00 | 250,743,000.00 | 153,050,000.00 | ||||||||||||||
Income Before Tax Ratio | (0.04%) | (0.09%) | (0.14%) | (0.06%) | (0.03%) | ||||||||||||||
Income Tax Expense | |||||||||||||||||||
Income Tax Expense | 20,459,000.00 | 116,400,000.00 | 137,861,000.00 | 141,896,000.00 | 126,667,000.00 | ||||||||||||||
Net Income | |||||||||||||||||||
Net Income | 79,346,000.00
+0% |
129,671,000.00
+63% |
380,100,000.00
+193% |
116,181,000.00
-69% |
5,959,000.00
-95% |
||||||||||||||
Net Income Ratio | (0.03%) | (0.04%) | (0.10%) | (0.03%) | (0.00%) | ||||||||||||||
Earning Per Share | |||||||||||||||||||
Basic EPS | 9.26 | 15.36 | 43.44 | 12.97 | 0.66 | ||||||||||||||
Diluted EPS | 9.26 | 15.36 | 43.44 | 12.97 | 0.66 | ||||||||||||||
Share Outstanding | |||||||||||||||||||
Basic Share Outstanding | 8,573,672.00 | 8,442,493.00 | 8,750,675.00 | 8,960,829.00 | 9,045,271.00 | ||||||||||||||
Diluted Share Outstanding | 8,573,672.00 | 8,442,493.00 | 8,750,675.00 | 8,960,829.00 | 9,045,270.00 |